Phase I Trial of Oral PX-866
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
Administration of BIIB028 to Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Trial of Oral Ixabepilone
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study of OSI-930 and Erlotinib in Cancer Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE1
Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1